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Non-coding RNAs can modulate histone modifica-
tions that, at the same time, affect transcript expres-
sion levels. Here, we dissect such a network in
mouse embryonic stem cells (ESCs). It regulates
the activity of the reverse transcriptase telomerase,
which synthesizes telomeric repeats at the chromo-
some ends. We find that histone H3 serine 10 phos-
phorylation set by Aurora kinase B (AURKB) in
ESCs during the S phase of the cell cycle at centro-
meric and (sub)telomeric loci promotes the expres-
sion of non-coding minor satellite RNA (cenRNA).
Inhibition of AURKB induces silencing of cenRNA
transcription and establishment of a repressive chro-
matin state with histone H3 lysine 9 trimethylation
and heterochromatin protein 1 accumulation. This
process results in a continuous shortening of telo-
meres. We further show that AURKB interacts
with both telomerase and cenRNA and activates
telomerase in trans. Thus, in mouse ESCs, telomere
maintenance is regulated via expression of cenRNA
in a cell-cycle-dependent manner.INTRODUCTION
Phosphorylation of serine 10 of histone H3 (H3S10p) by Aurora
kinase B (AURKB) is a well-established chromatin modification
of mitotic chromosomes (Adams et al., 2001; Honda et al.,
2003). During mitosis, H3S10 phosphorylation acts in concert
with H3K14 acetylation (H3K14ac) and induces the dissociation
of heterochromatin protein 1 (HP1) from chromatin (Fischle et al.,
2005; Mateescu et al., 2004). The latter protein interacts with the
SUV39H1 and SUV39H2 histone methylases (referred to here as
SUV39H) that catalyze the di- and trimethylation of histone H3 at
lysine 9 (H3K9me2/3) in pericentric heterochromatin (Aagaard
et al., 1999; Mu¨ller-Ott et al., 2014; Yamamoto and Sonoda,
2003). The H3K9me2/3 modification promotes HP1 binding to
nucleosomes carrying this modification via its chromodomain
that recognizes this mark (Fischle et al., 2003; Jacobs and
Khorasanizadeh, 2002). Thus, SUV39H, HP1, and AURKB areCepart of an epigenetic switch that mediates the transition be-
tween a repressive chromatin state (H3K9me2/3 and unmodified
H3S10 andH3K14) and amore open active chromatin conforma-
tion (H3S10p and H3K14ac) (Liokatis et al., 2012). The repressive
combination of H3K9me2/3 andHP1 suppresses transcription of
pericentromeric (Lehnertz et al., 2003; Martens et al., 2005) as
well as telomeric repeats (Arnoult et al., 2012). In contrast,
the relatively rare occurrence of H3S10p during interphase at
some genes has been related to enhanced transcription, prob-
ably by supporting an open chromatin structure (Ivaldi et al.,
2007; Labrador and Corces, 2003; Lee et al., 2006; Lo et al.,
2000; Nowak and Corces, 2004). Furthermore, H3S10 phos-
phorylation was found during S phase for the first two cell divi-
sions in embryogenesis (Teperek-Tkacz et al., 2010) and was
linked to replication of heterochromatin in ESCs (Brown et al.,
2013).
Here, we set out to investigate if a functional role of H3S10p-
mediated repeat transcription exists during interphase in mouse
embryonic stem cells (ESCs). We show that the production of
centromeric RNA from minor satellite repeats (referred to here
as cenRNA) is induced during the S phase of the cell cycle by
AURKB-dependent H3S10 phosphorylation at subtelomeric
regions. The resulting upregulation of cenRNA enhances the
activity of the reverse transcriptase telomerase in trans to main-
tain telomeric repeats at the chromosome ends. Additionally, we
show that AURKB interacts with both cenRNAs and TERT, the
protein subunit of telomerase. Thus, our study identifies a mech-
anism by which a histone H3 phosphorylation-methylation
switch controls cenRNA transcription and telomerase activity
in a cell-cycle-specific manner.RESULTS
AURKBPhosphorylates Centromeric and (Sub)telomeric
Loci at Chromosomal p-Arms in ESCs during S Phase
We investigated the H3S10p pattern in mouse ESCs by immuno-
fluorescence using the replication protein factor proliferating cell
nuclear antigen (PCNA) as a cell-cycle marker. During the G1
phase, hardly any H3S10p was detectable in ESCs. However,
distinct H3S10p foci became clearly visible during S phase adja-
cent to DAPI-dense regions (Figure 1A). The H3S10p foci per-
sisted during G2 when the characteristic H3S10p pattern in the
pericentric heterochromatin regions was established. AURKBll Reports 11, 1667–1678, June 16, 2015 ª2015 The Authors 1667
Figure 1. Appearance of H3S10p Domains and AURKB during the Cell Cycle
(A) Representative CLSM images of AURKB and H3S10p distribution in ESCs visualized by immunostaining during the cell cycle. PCNA-GFP was used as a
marker for cell-cycle stages, displaying a homogenous distribution in G1 and a punctuate pattern due to the appearance of replication foci in S phase. More than
90% of the ESCs that displayed this S phase PCNA nuclear distribution also had H3S10p foci. At this cell-cycle stage, AURKB was also detected by immu-
nostaining. The H3S10p foci persisted during G2, when H3S10p was enriched at DAPI-dense regions. Color-coding of merged image: H3S10P, green; AURKB,
red; DAPI, blue. Scale bars, 5 mm.
(B) Primary MEFs imaged as described for (A). AURKB and H3S10p were restricted to DAPI-dense regions in G2, and both were undetectable in G1 and S phase.
Scale bars, 5 mm.was homogenously distributed throughout the nucleus during S
phase as detected by immunostaining in ESCs with enrichments
at the H3S10p foci, while the signal was absent during G1 (Fig-
ure 1A). In contrast, the dot-like H3S10p distribution in S phase
was not detectable in primary mouse embryonic fibroblasts
(MEFs) (Figure 1B). In these cells AURKB expression was not de-
tected during S phase but the enzyme became enriched at peri-
centric heterochromatin in G2 (Figure 1B).
The H3S10p-rich foci observed during S phase in ESCs were
centered between the telomere and the centromere on the p-arm
of each chromosome as inferred from a three-color staining for
CENP-A, as a marker for the centromere and TRF2 to visualize
the telomeres (Figure 2A). From the confocal lasers scanning
microscopy (CLSM) 3D-image stacks we selected samples
that had the p-arm oriented in the x-y plane (Figure 2B, top panel)
or aligned along the optical axis/z axis of the microscope (Fig-
ure 2B, bottom panel). Comparison of the successive images
taken along the z axis showed that the phosphorylation mapped
to the chromosome p-arm and covered a region between
the centromeres and telomeres that extended into the corre-
sponding repeat sequences. Chromatin immunoprecipitation
sequencing (ChIP-seq) of histone H3 and H3S10p showed an
enrichment of H3S10p at centromeric repeats, but not at q arm
subtelomeres, as inferred from the read distributions for syn-
chronized ESCs (Figures S1A and S1B). In the unsynchronized
cells, mitotic H3S10p covered the whole chromosome and
dominated the signal with similar values for both regions.
Based on the above results we conclude that the H3S10p foci
observed during S phase comprise a part of the centromeres,
the subtelomeric regions, and a part of the telomere repeats at
the chromosome p-arm. In the following, we refer to them as
SPPs for (serine 10 phosphorylated p-arms) (Figure 2C). SPPs
were also observed in the widely used Oct4-GiP ESCs (Lowell1668 Cell Reports 11, 1667–1678, June 16, 2015 ª2015 The Authorset al., 2006) that express GFP under the control of the Oct4 pro-
moter and thus seem to be a general feature of mouse ESCs
(Figure S1C).
When stem cells were treated with AURKB inhibitors such
as reversine or ZM-447439, SPPs were essentially absent after
4 hr of treatment (Figure S1D). At a concentration of 1 mM, the
AURKB inhibitor ZM-447439 blocked H3S10 phosphorylation
during S phase, but not during mitosis, so that cells proliferated
and experiments with long-term AURKB inhibition could be con-
ducted. Under these conditions, ESCs displayed unchanged
morphology, Oct4 expression, and cell-cycle properties for up
to 15 weeks (Figures S1E–S1I). In addition, cell-cycle kinetics
were comparable as shown by a release from a mitotic arrest
(Figure S1J). Thus, at a 1-mMZM-447439 inhibitor concentration,
AURKB was selectively inhibited in S phase in the whole cell
population and SPPs were lost without inducing cell-cycle de-
fects, such as anaphase bridges (Figure S2E) or differentiation.
The possibility to selectively inhibit AURKB activity at SPPs in
S phase at low inhibitor concentrations (Figure S2D) can be ratio-
nalized by the increase of AURKB expression from S phase to a
maximum in mitosis as shown by fluorescence-activated cell
sorting (FACS) (Figures S2A and S2B). In addition, we show
that knockdown of AURKB also diminishes H3S10p in S phase
in ESCs (Figure S2C). These results demonstrate that SPPs orig-
inate from the activity of AURKB acting as both an interphase
and a mitotic kinase in ESCs.
Centromeric Transcription Is Regulated by the Interplay
of H3K9 Methylation, H3S10 Phosphorylation, and HP1
Binding at SPPs
Since Suv39h1/h2 double-null (Suv39h dn) immortalized mouse
embryonic fibroblasts (iMEFs) show an elevated level of H3S10p
during interphase (Peters et al., 2001), we analyzed their H3S10p
Figure 2. Chromosomal Location of H3S10p
Foci in ESCs
(A) Representative CLSM immunofluorescence im-
agesofcentromere, telomere,andH3S10p inESCs.
Staining of CENP-A (blue) and H3S10p (green) and
transfection of RFP-TRF2 (red) showed that the
H3S10p foci were located near every centromere.
Scale bars, 5 mm.
(B) Stack of enlarged optical sections taken along
the optical axis of the confocal microscopy
images for two different chromosomes. The upper
series shows images, in which H3S10p (green), the
centromere (blue), and the telomere (red) are in the
same image plane. The bottom series displays
a view with the centromere, H3S10p, and the
telomere appearing sequentially, i.e., the p-arm
chromosome was located perpendicular to the
image plane. Scale bars, 0.5 mm.
(C) Scheme for chromosomal location of H3S10p
foci. Serine 10 phosphorylated p-arm loci, referred
to here as SPPs (green), were located between the
centromere (blue) and telomere (red) of the p-arm
and partially overlapped with the centromeric and
telomeric regions.
See also Figures S1 and S2.pattern by immunostaining. We detected SPPs in Suv39h dn
iMEFs that were undistinguishable from those found in ESCs
(Figure S3). Next, it was tested whether the SUV39H-medi-
ated H3K9me2/3 modification suppresses phosphorylation of
H3S10. To this end, wild-type SUV39H1 or the inactive H324L
mutant and PCNA-RFP, a fusion protein of PCNA (proliferating
cell nuclear antigen), and red fluorescent protein (RFP), were
transfected into ESCs. Then, the number of SPPs was counted
and compared to cells transfected only with PCNA-RFP (Fig-
ure 3A). The overall number of SPPs was reduced from 23 ± 1
in wild-type cells to 8 ± 1 in Suv39h1 transfected cells (error
bar corresponds to SEM; p value < 0.001, t test) (Figure 3A).
The inactive Suv39h1 mutant did not influence the formation of
SPPs. To exclude that the H3S10p antibody is negatively
affected by H3K9me3, we assessed its specificity with a histone
peptide array (Figure S4A). The results show that the antibody
specifically detects H3S10p independent of the absence or
presence of adjacent lysine 9 methylation.
HP1 isoforms alpha, beta, and gamma bind to both the centro-
mere and the pericentric major satellite repeats, where its pres-
ence correlates with H3K9me3 and chromatin silencing (Fodor
et al., 2010; Mu¨ller-Ott et al., 2014). HP1 is released during G2
from the (peri)centromeres by the combination of H3S10p and
H3K14ac modifications (Fischle et al., 2005; Mateescu et al.,
2004). Accordingly, we investigated if H3S10p in SPPs was
accompanied by acetylation of lysine 14. We found that this
was indeed the case in both ESCs and Suv39h dn iMEFs (Fig-
ure S4B). Since the combination of H3S10p and H3K14ac is
incompatible with HP1 binding, we evaluated the presence of
HP1a at SPPs. We found that HP1a-rich foci formed at subtelo-
meric regions upon AURKB inhibition in S phase (Figures 3B and
3C). Knockdown of AURKB resulted in the same relocalization of
HP1a as AURKB inhibition (Figure S4C). In addition, H3K9me3
levels increased at SPPs upon AURKB inhibition (Figure 3B).CeWe conclude that HP1 and H3K9me3 accumulation—two proto-
typic features of a transcriptionally silent state—were absent in
SPPs due to AURKB activity.
Since SPPs were only detectable at the short arm subtelo-
meric regions, we measured transcript levels from these regions
in dependence of the H3S10p state modulated by the inhibition
of AURKB with ZM-447439. Transcription of major and minor
satellite repeats from the (peri)centromeres as well as the
expression of the telomeric RNA TERRA were quantitated by
real-time PCR. TERRA levels and major satellite transcripts
(pcRNA) hardly changed after inhibition of AURKB for 48 hr,
whereas minor satellite transcripts from the centromere (cen-
RNA) were reduced by 54% ± 2% (p value < 0.01, t test) (Fig-
ure 3D). Absence of genomic DNA was confirmed by real-time
PCR (Figure S4D). Since it was reported that centromeric tran-
scripts are double stranded (Martens et al., 2005), we also
checked strand-specific changes of cenRNA levels. Via cDNA
synthesis with primers for the forward and the reverse transcript
and subsequent real-time PCR quantification a reduction of
both transcripts by 50% (p value < 0.05, t test) upon AURKB
inhibition was measured (Figure 3E).
Expression of cenRNA was followed through the cell cycle by
synchronizing the ESCs with aphidicolin in G1. ESCs had hardly
progressed 2 hr after released from the cell-cycle arrest, and the
majority still resided at the G1/S border (Figure S4E). After 5 hr,
most cells had entered S phase, and some had proceeded into
G2. The presence of ZM-447439 did not affect cell-cycle pro-
gression (Figure S4E). The transcription level of the centromeric
repeats was measured by real-time PCR relative to that of the
control cells and normalized to Gapdh transcripts (Figure S4F).
When AURKB was inhibited, cenRNA expression was indepen-
dent of cell-cycle progression. Without the inhibitor, cenRNA
expression reached its maximum 5 hr after release, which was
1.7-fold higher than in arrested cells and 2.5-fold higher than inll Reports 11, 1667–1678, June 16, 2015 ª2015 The Authors 1669
Figure 3. Analysis of H3S10p, SUV39H1 Ac-
tivity, HP1 Binding, and cenRNA Expression
(A) CLSM images of H3S10p in ESCs over-
expressing SUV39H1. ESCs were transfected
with plasmids for overexpression of GFP-tagged
WT SUV39H1 or the catalytically inactive H324L
mutant and PCNA-RFP or only with PCNA-RFP
and stained for H3S10p. Scale bar, 5 mm. The box
plot displays the quantification of the H3S10p foci.
Most cells transfected with Suv39h1 showed
approximately eight H3S10p foci in S phase,
whereas more than 23 foci were counted in control
cells residing in S phase (n > 70). See also Figure S3
for SPPs in Suv39 dn cells and Figure S4A for
specificity of the H3S10p antibody used here.
(B) HP1distribution in ESCsafter AURKB inhibition.
In ESC control cells, HP1 showed some enrich-
ment at DAPI-dense regions and was otherwise
homogenously distributed. Upon AURKB inhibi-
tion, HP1 formed distinct foci in S phase. In the
merged image HP1 is shown in green, TRF2 in red,
and DAPI in blue. Scale bars, 5 mm. ChIP-PCR
shows enrichment of H3K9me3 at centromeres,
but not at pericentric heterochromatin (PCH) after
AURKB inhibition. Error bars correspond to the
SD of three independent replicates. See also
Figure S4C for siRNA knockdown of AURKB.
(C) Localization of HP1 foci induced by AURKB
inhibition. Sites with HP1 enrichment were located
at the p-arm and overlapped with centromeres and
telomeres (see white arrows) like the SPPs that
were lost due to AURKB inhibition. In the merged
image HP1 is shown in green, TRF2 in red, and
CENP-A in blue. Scale bar, 5 mm.
(D) RNA quantification after AURKB inhibition by
real-time PCR. Values were normalized using
b-actin, while Gapdh served as an internal control.
A reduction of cenRNA in ZM-447439-treated cells
was observed after 48 hr. Error bars correspond
to the SD of three independent replicates. See
also Figure S4D confirming the absence of
genomic DNA.
(E) Strand-specific real-time PCR of cenRNA. Both
cenRNAf and cenRNAr transcripts were reduced
upon AUKRB inhibition. Error bars correspond to
the SD of three independent replicates.
See also Figures S4E and S4F for cell-cycle-
dependent cenRNA expression.ZM-447439-treated cells after release (p value < 0.05, t test).
Thus, cenRNA expression was highest during S phase and
dependent on AURKB.
AURKB Inhibition Leads to Telomere Shortening due to
Lack of cenRNA
It has been shown that chromatin organization plays an impor-
tant role in telomere maintenance (Blasco, 2007). As SPPs were
located near the p-arm telomere and are needed for an open
chromatin structure, we investigated whether SPPs and
AURKB activity had an effect on telomere repeat maintenance
at the p-arm. We determined total telomere length by fluores-
cence in situ hybridization against the telomere repeats1670 Cell Reports 11, 1667–1678, June 16, 2015 ª2015 The Authorscoupled with flow cytometric quantification (flow-FISH).
H3S10 phosphorylation was blocked in S phase with ZM-
447439 for up to 15 weeks. Wild-type ESCs were compared
with ZM-447439-treated cells after 4 and 15 weeks and wild-
type cells that were cultured for 15 weeks in the absence of
the AURKB inhibitor. The telomere length remained unchanged
for untreated ESCs during this period. However, the ZM-
447439-treated cells displayed a progressive telomere short-
ening over time (Figure 4A). After 4 weeks, telomeres were
shortened by 6% ± 3% and by 11% ± 2% after 15 weeks. Telo-
mere replication was not affected and still occurred early during
the onset of S phase in both treated and untreated cells
(Figure S5A).
Figure 4. Reduction of Telomerase Activity upon AURKB Inhibition and cenRNA Knockdown
(A) Flow-FISH measurements of telomere length. Cells were cultured for up to 15 weeks untreated (control) or treated with ZM-447439 (+ZM). After that period,
control cells had the same telomere length distribution as cells at the beginning of the experiment (blue and red line). Time points after 4 weeks (+ZM 4 w, green)
and 15 weeks (+ZM 15 w, orange) show progressive loss of telomere signal indicating shortening of telomeres due to treatment with ZM-447439. Average curves
calculated from three independent replicates are shown. The two peaks of all curves correspond to cells without (first peak) and with (second peak) replicated
telomeres, hence the doubling of the signal intensity. See also Figure S5A for replication timing of telomeres.
(B) Histograms of the telomere probe intensity of the q-arm telomere for ZM-447439 (+ZM) treated and control cells. Error bars correspond to the SD.
(C) Same as (B), but for p-arm telomeres. Both q- and p-arm telomeres showed a shift to lower intensities indicative of loss of repeats upon ZM-447439 treatment.
Error bars correspond to the SD.
(D) Recruitment of AURKB by GFP-TERT bound to lacO-arrays. GFP-TERT was tethered to lacO-arrays in telomerase-negative U2OS cells, and subsequent
binding of RFP-AURKB was evaluated. GFP served as a negative control. The bar plot gives the percentage of cells with positive recruitment. RFP-AURKB was
clearly enriched when GFP-TERT was tethered to the lacO arrays. Error bars correspond to the SE from more than 50 cells. Scale bars, 5 mm.
(E) Quantification of telomerase activity measured in a quantitative TRAP assay. Telomerase activity was largely reduced by AURKB inhibition and cenRNA
knockdown. Buffer and RNase-A-treated cell extracts served as negative controls. Error bars correspond to the SD. See also Figure S5 for expression levels of
TERT and TERC.Next, telomere length was assessed onmetaphase spreads to
separately evaluate shortening at the p and q arm of each chro-
mosome. An overall shortening of 15% ± 2% (p value < 0.001,
t test) was measured for the ZM-447439-treated cells after
15 weeks as compared to their wild-type controls, which is in
excellent agreement with the flow-FISH analysis. Interestingly,
both telomeres at p and q arm were shortened (p value <Ce0.001, t test) (Figures 4B and 4C), indicating that the H3S10p-
dependent telomere maintenance mechanism acts in trans and
not in cis. To exclude the possibility, that AURKB activity directly
affects expression of telomerase, we confirmed that transcrip-
tion of Tert and Terc encoding for the telomerase protein and
RNA component, respectively, remained unchanged upon inhi-
bition of AURKB (Figures S5B and S5C). Furthermore, well Reports 11, 1667–1678, June 16, 2015 ª2015 The Authors 1671
prepared two independent RNA-sequencing (RNA-seq) libraries
fromwild-type aswell as fromAURKB inhibitor-treated cells. Dif-
ferential expression analysis with the DESeq software identified
ten upregulated and no downregulated genes at the p < 0.01 sig-
nificance level (Table S1). None of the upregulated genes had
any apparent link to the observed interference with telomere
maintenance.
We next tested in living cells if AURKB and TERT interact with
each other, whichmight indicate a direct link between AURKB in-
hibition and telomere shortening. Mouse GFP-tagged TERT was
tethered to lacO-arrays integrated at two chromosomes in a hu-
man U2OS cell line as described previously (Chung et al., 2011).
This led to a strong enrichment of RFP-AURKB at the two loci
with tethered GFP-TERT (Figure 4D). In contrast, tethering only
the GFP protein did not recruit AURKB. This demonstrates that
AURKB interacts with TERT in living cells.
To examine whether telomerase activity was impaired by
either AURKB inhibition or depletion of cenRNA, we measured
telomerase activity with a quantitative telomeric repeat ampl-
ification protocol (TRAP) assay (Herbert et al., 2006). We
compared wild-type cells with ZM-447439-treated cells and
cells transfected with two chimeric RNA-DNA oligomers for cen-
RNA knockdown by RNase-H-mediated degradation (Liang
et al., 2011). One of these antisense oligonucleotides targeted
the minor satellite forward transcript (cenRNAf), while the other
was complementary to the reversely transcribed RNA (cenRNAr).
Transfection with the two knockdown oligonucleotides resulted
in a 70% reduction of cenRNA (p value < 0.001, t test) as
measured by real-time PCR (Figure S6A). Both AURKB inhibition
and cenRNA knockdown led to a reduction of telomerase activity
of 50%and 40%, respectively (p value < 0.001, t test) (Figure 4E).
The linear relationship between protein content and telomerase
activity and dynamic range of the TRAP analysis is depicted in
Figure S6B.
Interestingly, the Suv39h dn iMEFs showed a 22-fold higher
expression level of cenRNA as compared to wild-type iMEFs
(p value < 0.001, t test) (Figure S5D). In contrast, the Tert expres-
sion level was 22-fold lower in the Suv39h dn than in wild-type
iMEFs (p value < 0.001, t test), while Terc expression and telome-
rase activity were similar in both cell types (Figures S5D andS5E).
Accordingly, we speculate that telomerase activity in Suv39h dn
cells is maintained by overexpression of cenRNA and AURKB
(Figure S5D) to compensate for the much lower TERT levels.
Telomerase Activity Loss Can Be Rescued by Ectopic
cenRNA Expression
Since it was previously reported that cenRNA can enhance
AURKB activity (Ferri et al., 2009), we extended the cenRNAf
and cenRNAr sequences with an RNA fragment that contained
eight MS2 stem loops. The resulting MS2-cenRNAf and MS2-
cenRNAr constructs were tethered to lacO-arrays via a fusion
construct of LacI-RFP with the MS2 binding protein (LacI-RFP-
MS2). Both MS2-cenRNAf and MS2-cenRNAr tethered to the
lacO integration sites induced a clear recruitment of GFP-
AURKB to these loci (Figure 5A). In contrast, binding of only
the MS2 stem loop containing RNA to the lacO-arrays did not
lead to an enrichment of GFP-AURKB. Based on these findings,
we propose that the cenRNA-mediated enhancement of telo-1672 Cell Reports 11, 1667–1678, June 16, 2015 ª2015 The Authorsmerase activity in ESCs occurs via interactions of a cenRNA-
AURKB complex with the TERT subunit of telomerase. It is noted
that this mechanism explains how AURKB inhibition and
subsequent repression of cenRNA transcription via epigenetic
silencing affects telomere repeat extension in trans.
To corroborate the functional relationship of cenRNAs and
AURKB for regulating telomerase activity, we tested whether
telomerase activity could be rescued by overexpression of these
RNAs after AURKB inhibition. To this end, we cloned the minor
satellite repeat sequence in an expression vector with an RNA
polymerase III promoter and transfected AURKB inhibited
cells twice over 48 hr. Expression of cenRNA was increased
3.5-fold and 1.8-fold over the mock control (empty vector) in
transfected wild-type cells for the forward and reverse tran-
scripts, respectively (Figures S6C and S6D). Telomerase activity
was compared between wild-type cells and ZM-447439-treated
cells. ZM-447439-treated cells were either untransfected or
transfected with the empty vector (‘‘Mock’’) or cenRNAf and
cenRNAr expression constructs (Figure 5B). Only cells express-
ing cenRNAf and cenRNAr simultaneously showed a significant
rescue of telomerase activity compared to mock transfection
and untransfected ZM-447439-treated cells. Thus, we conclude
that the active form of cenRNA is double stranded.
Next, we in vitro translated AURKB and TERT and performed
in vitro phosphorylation of TERT by AURKB. The telomerase ac-
tivity was measured in the absence or presence of wild-type
AURKB or inactive mutants, cenRNA, and major satellite RNA
from the pericentromeric repeats. Telomerase activity was
elevated by AURKB alone, but not by inactive AURKB mutants.
It further increased by the addition of cenRNA, but not by the
pcRNA repeat sequence of similar length from the major satellite
repeat (Figure 5C). We conclude that cenRNA acts as an
enhancer of an AURKB-mediated telomerase activation.
DISCUSSION
Centromeric minor satellite repeat sequences are actively tran-
scribed to yield double-stranded transcripts of heterogeneous
length from 25 up to several thousand base pairs, depending
on the activity of the endoribonuclease Dicer (Kanellopoulou
et al., 2005; Martens et al., 2005). The overexpression of these
RNAs referred to here as cenRNAs induce a chromosome segre-
gation defect phenotype (Bouzinba-Segard et al., 2006), but their
specific cellular activities have remained enigmatic. Here, we
show that AURKB-driven histone H3 serine 10 phosphorylation
enhances cenRNA expression in mouse ESCs during the S
phase of the cell cycle.
Since all mouse chromosomes are acrocentric, the centro-
meres are adjacent to the short arm telomere, with only a small
variable linker region separating these two chromosomal re-
gions (Guenatri et al., 2004; Kalitsis et al., 2006; Sasaki et al.,
2013). The center of the H3S10p-rich SPP loci was mapped
by CLSM analysis to this subtelomeric region between the
centromere and the telomere on the p-arm of each mouse chro-
mosome but also extended to the flanking parts of the genome.
ChIP-seq analysis of H3S10p showed that H3S10p was also en-
riched at the centromeric repeats themselves. Since inhibition of
H3S10p affected only the transcription of the centromere
Figure 5. Interaction of cenRNA with AURKB and Telomerase Activity Enhancement
(A) Recruitment of AURKB by cenRNAs bound to lacO-arrays. MS2-cenRNA was tethered to lacO-arrays by the LacI-RFP-MS2-coat fusion protein. The bar plot
gives the percentage of cells with positive recruitment. Recruitment of GFP-AURKB was observed with both MS2-cenRNAf and MS2-cenRNAr, whereas MS2
stem loops did not induce an enrichment of GFP-AURKB. The dashed line in the upper row indicates the position of the nucleus. Error bars correspond to the SE
from more than 50 cells. Scale bars, 5 mm.
(B) Rescue of telomerase activity by cenRNA overexpression measured in a TRAP assay. While transfection with an empty plasmid showed no effect, simul-
taneous expression of cenRNAf and cenRNAr resulted in partial rescue of telomerase activity. Error bars correspond to the SD of three replicates. See also
Figure S6 for overexpression of cenRNAs.
(C) Telomerase activity is increased by AURKB and cenRNA. AURKB, TERT, and RNAs were in vitro translated and assembled in a phosphorylation buffer, and
telomerase activity was measured in a TRAP assay. Activity was highest when TERT and TERC were mixed with AURKB and cenRNAs. Error bars correspond to
the SD of three replicates.repeats, but not that of major repeats or telomeric transcripts,
we speculate that the SPPs contain promoter and/or enhancer
regions for cenRNAs and that the phosphorylation also contrib-
utes to a transcription permissive chromatin structure within the
repeats. Activation of their transcription by H3S10p could also
involve H3K14ac, which was found to be associated with
H3S10p in SPPs. Similar to the molecular events that occur dur-
ing mitosis (Fischle et al., 2005), HP1 became depleted from
SPPs by the H3S10p and H3K14ac histone modifications,
which is likely to promote transcription of the centromeric re-
peats. In contrast, AURKB inhibition resulted in HP1 binding
to this region and silencing of cenRNA expression. The forma-
tion of SPPs was counteracted by the activity of SUV39H-driven
H3K9 di/trimethylation as concluded from Suv39h dn fibroblasts
having SPPs and high levels of cenRNA and the reduction of
SPPs/H3S10p levels upon overexpression of SUV39H1 in
ESCs.
Thus, the previously described network of SUV39H1/2-driven
H3K9 di/trimethylation, the recognition of this modification by
HP1, and the counteracting process of H3S10 phosphorylationCefollowed by H3K14 acetylation operate in mouse ESCs to regu-
late cenRNA transcription during the S phase of the cell cycle.
Upregulating cenRNA by this histone phosphorylation-methyl-
ation switch is of functional importance, since it is required for
efficient telomere elongation. This is consistent with the finding
that telomerase is mostly active during S phase after the telo-
meres have already been replicated (Ja´dy et al., 2006; Tomlinson
et al., 2008; Zhao et al., 2008).
Interestingly, it has been reported previously that telomerase
processivity isaffectedbyposttranslational histonemodifications.
Telomeric chromatin in differentiatedmouse cells lacking telome-
raseactivity is ina repressiveheterochromatic state that ischarac-
terized by histone H3K9me3 and binding of HP1 (Benetti et al.,
2007b; Garcı´a-Cao et al., 2004). Depletion of the histone methyl-
ases SUV4-20H1/H2 (catalyzing H4K20me3) and SUV39H1/H2
leads to aberrant telomere elongation (Benetti et al., 2007a,
2007b). At the same time, overexpression of SUV39H1 in mice
results in telomere shortening (Petti et al., 2015), which is in line
with the finding reported in our study on suppression of SPPs
and cenRNA expression by enhanced SUV39H1 activity.ll Reports 11, 1667–1678, June 16, 2015 ª2015 The Authors 1673
Figure 6. Model for Telomerase Activation by cenRNA via a Histone
Phospho-Methylation Switch
AURKB expression leads to the formation of SPPs between the centromere
and telomere, which induces cenRNA expression. In turn, cenRNAs bind to
AURKB and this complex interacts with TERT to enhance telomerase activity
needed for efficient telomere elongation. Telomerase activation is impaired by
AURKB inhibition and cenRNA knockdown. In addition, SUV39H activity
promotes H3K9me3 and HP1 binding to induce a chromatin state that coun-
teracts H3S10p formation during S phase and silences cenRNA expression.In mouse ESCs, however, the telomeres lack these typical het-
erochromatin markers and telomerase is active. Induction of a
heterochromatic chromatin state at SPPs by AURKB inhibition
did affect telomere repeat extension in trans as shown by
the telomere intensity analysis (Figures 4B and 4C). Furthermore,
we identified a specific mechanism in ESCs, by which SUV39H,
H3K9me3, and HP1 counteracted the transcriptionally active
chromatin state that was established during S phase via the
H3S10p modification. In the active state, the extension of telo-
mere repeats by telomerase was promoted via upregulation of
cenRNA. Both AURKB inhibition and the knockdown of cenRNA
resulted in a less active telomerase complex (Figure 4E). This
conclusion is supported by the previously reported finding that1674 Cell Reports 11, 1667–1678, June 16, 2015 ª2015 The Authorsknockdown of AURKB results in a reduced telomerase activity
in human cancer cell lines (Cerone et al., 2011). In the latter
study, however, it remained unclear, whether this effect resulted
from mitotic defects and/or cell-cycle arrest. In our study,
AURKB was selectively inhibited in S phase and cell division
was not impaired, and hence we can rule out cell-cycle effects
on telomerase activity. Additionally, we did not observe changes
in Tert or Terc expression when AURKB was inhibited.
Notably, long-term inhibition of AURKB resulted in a constant
loss of telomere repeats in ESCs. Interestingly, Suv39h dn iMEFs
had a 22-fold reduced Tert level, while the level of cenRNA was
22-fold increased as compared to the wild-type fibroblasts. This
finding suggests that a low level of Tert expression was sufficient
to ensure immortalization of Suv39h dn embryonic fibroblasts,
as the higher cenRNA and AURKB levels in S phase provides
sufficient telomerase activation at relatively low TERT concen-
trations. In this manner, a telomerase activity level could be
obtained for Suv39h dn cells that was comparable to the wild-
type immortalized fibroblasts.
In-vitro-translated telomerase was more efficient in the TRAP
assay in combination with AURKB. This clearly shows that
AURKB can indeed accelerate telomerase activity. In contrast
to RNA frommajor satellite repeats, in-vitro-transcribed cenRNA
further increased telomerase activity. This is fully consistent with
our observation of reduced telomerase activity after knockdown
of cenRNA (Figures 4E and 5C), while the overexpression of
cenRNA partially rescued the loss of telomerase activity upon
AURKB inhibition (Figure 5B).
Our findings link cenRNA, AURKB, and TERT activity and are
summarized in the scheme depicted in Figure 6. After replica-
tion of telomeres, H3S10 phosphorylation by AURKB induces
cenRNA expression during S phase. Via interaction of the
cenRNA-AURKB complex with TERT, the telomerase complex
is activated in trans to compensate the loss of telomere repeats
that occurred during replication. This activation step could
involve the formation of telomerase dimers, which have been
proposed to be more active in such a complex (Wenz et al.,
2001) and/or an increase the enzyme’s processivity by phos-
phorylation of TERT. Phosphorylation of TERT, e.g., by Akt,
has been associated with telomerase activity (Haendeler et al.,
2003; Seimiya et al., 1999), whereas dephosphorylation by pro-
tein phosphatase 2A inhibits TERT in vitro (Li et al., 1997; Xi et al.,
2013). It is thus conceivable that AURKB regulates TERT activity
by phosphorylation. Since cenRNA also enhances AURKB
activity (Ferri et al., 2009), the underlying network could include
a feedback loop in which these transcripts further promote
H3S10p formation. SUV39H promotes a chromatin state in
which H3K9me3 and HP1 binding suppress H3S10p and
cenRNA expression as inferred from the analysis of Suv39h
dn cell and overexpression of SUV39H1. Thus, via regulating
cenRNA expression by a cell-cycle-dependent histonemodifica-
tion switch, telomerase activity in mouse ESCs is synchronized
with telomere replication. Modulating telomerase activity in this
manner has a number of implications for tumorigenesis as well
as reprogramming of somatic cells, since activation and regula-
tion of telomere maintenance is a crucial step in both processes.
Therefore, we anticipate that investigating the role of the
epigenetic network revealed here in other cellular systems will
Table 1. Primers Used for Real-Time PCR
Target Sequences in the 50-30 Direction
Telomere fwd CGGTTTGTTTGGGTTTGGGTTTGGGTTT
GGGTTTGGGTT
Telomere rev GGCTTGCCTTACCCTTACCCTTACCCTT
ACCCTTACCCT
cenRNAf AATGATAAAAACCACACTGTAGAACAT
cenRNAr ATGTTTCTC ATTGTAACTCATTGATATAC
Major repeat fwd TGGCGAGAAAACTGAAAATCACG
Major repeat rev TCTTGCCATATTCCACGTCCTAC
b-Actin fwd TATCCTGACCCTGAAGTACC
b-Actin rev CTCGGTGAGCAGCACAGGG
Gapdh fwd TATGTCGTGGAGTCTACTGG
Gapdh rev ACACCCATCACAAACATGGG
Tert fwd TAGAGGATTGCCACTGGCTCC
Tert rev AGCTGTACCACGTATGTGTCC
Terc fwd GGTTCTGGTCTTTTGTTCTCCG
Terc rev TTTTGAGGCTCGGGAACGCGprovide valuable information on the linkage between changes of
(sub)telomeric and/or centromeric chromatin and functional cell
states via cenRNA effector transcripts.EXPERIMENTAL PROCEDURES
Cell Culture
129/Ola ESCs (Mallm et al., 2010) used for this study were cultured in
Powerstem ESPRO1 (PAN) on gelatin-coated surfaces. GIP-ESCs were main-
tained in ESGRO complete (Millipore) without feeders on gelatin. 129/Ola-Hsd
MEFs were generated from pregnant embryonic day 13.5 (E13.5) mice and
cultured in DMEM supplemented with 10% fetal calf serum and glutamine
up to passage five. The same medium was used to culture SUV39H1/h2 dou-
ble-null cells and wild-type iMEFs (Peters et al., 2001).
Immunofluorescence and Western Blotting
For immunostaining and transfection, cells were seeded on Matrigel-coated
coverslips. Vectors for overexpression of RFP-TRF2, GFP-PCNA, RFP-
PCNA, GFP-SUV39H1, and the GFP-SUV39H1 H324L inactive mutant were
transfected with lipofectamine 2000. Fixed and stained cells were mounted
with Prolong containing DAPI (Invitrogen) and examined using a Leica TCS
SP5 confocal laser-scanning microscope equipped with a 633/1.4 numerical
aperture oil-immersion objective lens (Leica Microsystems CMS). For AUKRB
knockdown, small interfering RNA (siRNA) (Ambion, s74513) was transfected
with lipofectamine 3000 and cells were fixed 36 hr after transfection.
For immunostaining and western blots, the following antibodies were used:
AURKB (6/AIM-1, BD Bioscience), CENP-A (2048, Cell Signaling), GAPDH
(AM4300, Ambion), histone H3S10p (ab14955, Abcam, for all experiments
except immunofluorescence with AURKB, when ab5176 [Abcam] was used),
histone H3S10pK14ac (07-081, Millipore), HP1-alpha (2HP-1H5, Euromedex),
OCT4 (ab279985, Abcam), TERT (H-231, Santa Cruz). The specificity of the
ab14955 H3S10p antibody was verified with the ‘‘MODified Histone Peptide
Array’’ (ActiveMotif) according to themanufacturer’s instructions (Figure S4A).
Counting of H3S10p foci after transfection with GFP-SUV39H1 and GFP-
SUV39H1H324L mutant was done using ImageJ software. First, the back-
ground of the H3S10p staining in the nucleus was determined and a threshold
was applied, which was three times higher then the background. Then,
H3S10p foci were automatically detected within the nucleus with the
constraint that their size had to be in the range from 0.05 to 2 mm2.CeTotal RNA Extraction and Real-Time PCR
Total RNA was extracted with the RNeasy kit (QIAGEN) following themanufac-
turer’s instructions. Total RNAwas subsequently digestedwith DNase I for 1 hr
to ensure depletion of contaminating genomic DNA. 2 mg total RNA was used
for cDNA first-strand synthesis using superscript II reverse transcriptase (Invi-
trogen), which was followed by RNase H treatment. For quantification, a cDNA
standard was prepared that included five samples ranging from 25 ng/ml to
0.35 ng/ml. The standard curve was determined from real-time PCR with 2 ml
of each concentration using the SYBR Green I kit by Roche and the StepOne
RT-PCR system (Applied Biosystems) and subsequently used to quantify the
target cDNA. The following program was used for amplification: 95C for
10 min followed by 35 cycles with 95C, 60C, and 72C each for 10 s. Three
biological independent samples were used for each primer pair with three
replicates. Gapdh was used for normalization, and b-actin served an internal
control. Errors given in the graphics correspond to SEM.
Primers used for real-time PCR are listed in Table 1.
Cell-Cycle and Telomere-Length Flow-FISH Analysis by FACS
For cell-cycle analysis, cells were harvested and fixed with 70% ethanol for
2 hr on ice. After resuspension in staining buffer (PBS containing 100 mg/ml
RNase and 0.5 mM TO-PRO3), cells were analyzed with FACS Canto II. Cell-
cycle stages were fitted to DNA content profiles with the Weasel flow cytom-
etry data analysis software. For flow-FISH, cells were permeabilized with
0.25% Triton after ethanol fixation. Cells were washed with a buffer containing
5% glucose, 10 mMHEPES (pH 8.0), and 0.1% BSA and were resuspended in
hybridization buffer (75% deionized formamide, 20 mM Tris-HCl [pH 7.4],
20mMNaCl, and 0.1%BSA) with 55 nMPNA (peptide nucleic acid) fluorescein
isothiocyanate telC probe (Pangene). After 15 min at 87C, hybridization was
allowed for 90 min at room temperature, and cells were subsequently washed
with a buffer containing 70% formamide, 0.1% BSA, 0.1% Tween-20, and
20 mM Tris-HCl (pH 7.4) three times and then washed with a buffer containing
5% glucose, 10 mM HEPES (pH 7.4), 0.1% BSA, and 0.1% Tween-20. Cells
were resuspended in staining buffer and analyzed the same day. For each
sample, three independent hybridizations were performed.
Protein expression of AURKBwasmeasured by fixing cells with 1% parafor-
maldehyde (PFA) for 10 min on ice, followed by ethanol fixation for 2 hr. After
permeabilizing with 0.25% Triton, the AURKB antibody was diluted 1:200 in
1% BSA/PBS and incubated overnight followed by an Alexa 488 secondary
antibody. Cells were resuspensed in staining buffer (PBS containing 100 mg/
ml RNase and 0.5 mM TO-PRO3) and analyzed with FACS Canto II.
For synchronization and release from a mitotic block, cells were arrested
with 200 nM nocodazole for 24 hr and released by three washes and mainte-
nance in medium.
Metaphase Spreads and Telomere FISH
Colcemid was added to the medium to a concentration of 0.02 mg/ml for 2 hr.
Cells were washed and incubated in 0.5% KCl and then fixed in methanol and
glacial acetic acid. Fixed nuclei were spotted in coverslips and washed with
ethanol. Cell nuclei were incubated with telomere PNA probes at 80C for
3 min after sealing the coverslips with Fixogum. Hybridization took place over-
night. After washes with 70% formamide, 23 SSC buffer (300 mM sodium
chloride and 30 mM sodium citrate), 0.13 SSC at 55C, and 0.05% Tween
in 23 SSC, metaphase spreads were dried with ethanol and eventually
mounted with Prolong (Invitrogen). For wild-type and inhibitor-treated cells,
a minimum of 2,000 telomeres were analyzed from two technical replicates.
Pictures were taken at the same day with the same laser settings. Pixel inten-
sities of telomere probes were measured with ImageJ.
RNA-Seq
Total RNA was purified as described above. Ribosomal RNA was removed
with the RiboZero kit (Epicenter) following the manufacturer’s instructions.
After fragmentation with the RNA Fragmentation Reagent (Ambion), cDNA
was generated with random primers and superscript II reverse transcriptase
(Invitrogen). After second-strand synthesis, the fragments were cloned into
an Illumina sequencing library according to standard protocols. Two biologi-
cally independent samples of wild-type and treated cells were submitted for
sequencing. After mapping with bowtie, differential expression was calculatedll Reports 11, 1667–1678, June 16, 2015 ª2015 The Authors 1675
with DESeq that was incorporated in the Genomatix software suite as
described previously (Teif et al., 2012).ChIP-Seq of H3S10p
ESCs were synchronized with 3 mg/ml aphidicolin for 20 hr. The cells were
released for 3 hr and subsequently cross-linked with 1% PFA. Cell nuclei
were prepared using a swelling buffer (25 mM HEPES [pH 7.8], 1 mM
MgCl2, 10 mM KCl, 0.1% NP-40, and 1 mM DTT). Chromatin was sheared
to mononucleosomal fragments with a Covaris S220 sonicator. After immu-
noglobulin G preclearance, the sheared chromatin was incubated with 4 mg
of either H3S10p (ab14955, Abcam) or histone H3 (ab4729, Abcam) antibody
and magnetic protein G beads overnight. The beads were washed with son-
ication buffer (10 mM Tris-HCl [pH 8.0], 200 mM NaCl, 1 mM EDTA, 0.5% N-
lauroylsarcosine, and 0.1% Na-deoxycholate), high-salt buffer (50 mM
HEPES [pH 7.9], 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-de-
oxycholate, and 0.1% SDS), lithium buffer (20 mM Tris-HCl [pH 8.0], 1 mM
EDTA, 250 mM LiCl, 0.5% NP-40, and 0.5% Na-deoxycholate), and
10 mM Tris-HCl (pH 6.8). Next, chromatin was eluted from the protein G
magnetic beads and the crosslink was reversed overnight at 65C. After
RNase A and proteinase K digestion, the DNA was purified and cloned
into a multiplexed Illumina library according to standard protocols.
Sequenced 50-bp reads were mapped to the mm9 assembly with custom-
ized bowtie indices. The number of mapped reads was normalized to the to-
tal number of reads.Quantification of Telomerase Activity with the TRAP Assay
Cells were harvested and lysed in TRAP lysis buffer for 30 min, which con-
tained 10 mM Tris-HCl (pH 7.4), 1 mM MgCl2,1 mM EDTA, 1% (v/v) NP-40,
0.25 mM sodium deoxycholate, 10% (v/v) glycerol, 150 mM NaCl, 5 mM mer-
captoethanol, and 1 U/ml Ribolock RNase inhibitor (Fermentas). After centrifu-
gation, the supernatant was collected and total protein concentration was
measured using the BCA assay (Thermo Scientific). A standard was prepared
that ranged from 0.125 ng/ml to 0.004 ng/ml total protein, and the samples were
diluted in lysis buffer to gain a concentration of 0.04 ng/ml. For each TRAP re-
action, 2 ml of the lysate were incubated with SYBR Green PCR master mix kit
(Applied Biosystems), 5 ng/ml TS primer (50-AATCCGTCGA GCAGAGTT-30),
5 ng/ml ACX primer (50-GCGCGGCTTACCCTTACCCTTACCCT AACC-30),
1 mM EGTA, and 1 U/ml Ribolock for 30 min at 30C. PCR was then run for
35 cycles with 15 s at 95C and 60 s at 60C.
The measured PCR threshold cycle (Ct) was transformed into an activity
value according to the standard curve. This allowed relative quantification of
the cell lysates with equal total protein concentration. Errors are given as the
SD of the three biological replicates, and the Student’s t test was used for sta-
tistical testing.
For rescue experiments, cells were treated with the AURKB inhibitor for
48 hr, then seeded on gelatin-coated 12-well plates and transfected with the
pBS/U6 plasmids (Grimm et al., 2006) within 3 hr. The cenRNAs were cloned
into the pBS/U6 plasmid via the Bbs I cloning site in both forward and reverse
directions. Expression of GFP from the same plasmid under the CMV promoter
was used to judge the transfection efficiency. The amount of cenRNA was
determined by PCR as described above. For each sample, three biological
replicates were performed. At 48 hr after transfection, cells were harvested
and subjected to a quantitative TRAP assay.Knockdown of cenRNA
For cenRNA knockdown, cells were transfected with RNA-DNA hybrid oligo-
nucleotides that consisted of five to six 20-O-MOE modified ribonucleotides
(shown in capital letter below) flanked by 14 deoxyribonucleotides with a phos-
phorothioate backbone at the 50 and 30 end. For knockdown of cenRNAf the
sequenceUGUAGaacagtgtatatcaAUGAGwas usedwhile the cenRNAr knock-
down was conducted with the UCAUCUaatatgttctacagUGUGGU oligonucleo-
tide. The two oligonucleotides used for knockdown were not complementary
to each other and were transfected into ESCs with Lipofectamine 2000 at a
final concentration of 50 nM each. Knockdown efficiency was determined
with real-time PCR of reverse-transcribed total RNA.1676 Cell Reports 11, 1667–1678, June 16, 2015 ª2015 The AuthorsProtein and RNA Recruitment and Interaction Analysis
GFP-tagged TERT was recruited via a LacI repressor-GFP binding domain
fusion protein to lacO-arrays integrated in telomerase-negative U2OS cells
as described previously (Chung et al., 2011; Jegou et al., 2009). Co-recruit-
ment of RFP-AURKB was measured 24 hr after transfection. Cells were fixed
and mounted with Prolong antifade reagent (Life Technologies). Images were
taken with a Leica SP5 microscope, and pictures were analyzed with ImageJ.
Signal intensity of RFP-AURKBwasmeasured at lacOarrays and regions adja-
cent to the lacO arrays. Positive recruitment was defined as the signal increase
at the lacO array by >1.5-fold as compared to adjacent regions. EGFP
recruited to lacO-arrays was used as a negative control. For RNA recruitment
experiments, one centromere repeat was fused to eight MS2 stem loops in
forward and reverse orientation. The fusion construct LacI-RFP-MS2-coat
protein was transfectedwith the tagged centromere repeats andGFP-AURKB.
Cells were fixed and imaged as described above. For statistical analysis of
AURKB recruitment either by TERT or by cenRNA, the Fisher’s exact test
was used.
In Vitro Phosphorylation of TERT
Open reading frames of AURKB and TERT were cloned into pET28(a)+ and
used for in vitro translation with rabbit reticulocyte lysates (RLL; Promega).
For in vitro translation of AURKB, 1 mg of plasmid was used, and for TERT,
1.5 mg plasmid plus 250 ng in-vitro-transcribed TERCwas used and incubated
according to the manufacturer’s instructions. AURKB mutants K111M and
D205A were generated by site-directed mutagenesis.
Lysates were directly used for in vitro phosphorylation using 2 ml AURKB
lysate and 10 ml TERT lysate in phosphorylation buffer (10 mM HEPES [pH
7.4], 150 mM NaCl, 10 mM MgCl2, and 1 mM EGTA) for 30 min at 37
C. The
phosphorylation reaction was then diluted in TRAP lysis buffer (1:25) and
used for a quantitative TRAP assay as described above.
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